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The machinery underlying malaria parasite
virulence is conserved between rodent
and human malaria parasites
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Sequestration of red blood cells infected with the human malaria parasite Plasmodium
falciparum in organs such as the brain is considered important for pathogenicity. A similar
phenomenon has been observed in mouse models of malaria, using the rodent parasite
Plasmodium berghei, but it is unclear whether the P. falciparum proteins known to be involved in
this process are conserved in the rodent parasite. Here we identify the P. berghei orthologues
of two such key factors of P. falciparum, SBP1 and MAHRP1. Red blood cells infected with
P. berghei parasites lacking SBP1 or MAHRP1a fail to bind the endothelial receptor CD36 and
show reduced sequestration and virulence in mice. Complementation of the mutant P. berghei
parasites with the respective P. falciparum SBP1 and MAHRP1 orthologues restores seques-
tration and virulence. These ﬁndings reveal evolutionary conservation of the machinery
underlying sequestration of divergent malaria parasites and support the notion that the
P. berghei rodent model is an adequate tool for research on malaria virulence.
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A
hallmark of Plasmodium falciparum malaria is the
adhesion of infected red blood cells (iRBCs) to the
endothelium of capillary venules, leading to sequestration
in multiple organs of the human host1,2. Sequestration is
associated with life-threatening complications and considered
to be central to the severe pathogenesis of this parasite3.
Sequestration of P. falciparum parasites is mediated by the
major virulence factor PfEMP1, a protein transported to the iRBC
surface that enables binding to endothelial host cell receptors
such as CD36 and ICAM1 (ref. 4). How sequestration of iRBCs
contributes to pathology is not fully understood and difﬁcult to
study in humans5. In rodent malaria models, which conveniently
allow in vivo virulence studies6–10, sequestration occurs11,12 but
PfEMP1 homologues are absent13.
For PfEMP1 to reach the iRBC cytosol, it ﬁrst traverses the
parasitophorous vacuole membrane (PVM) using a putative
translocon of exported proteins that is conserved among different
Plasmodium species and involved in transport of all exported
proteins14–16. In the host cell an elaborate machinery then
mediates further transport of PfEMP1 to the iRBC surface and the
proper surface display required for cytoadherence17–20. This
machinery was so far considered to be speciﬁc for the transport of
PfEMP1 in P. falciparum and does not seem to be required for the
trafﬁcking of other exported proteins17–20. This PfEMP1-speciﬁc
transport machinery was proposed as one possible reason for the
expansion of the number of exported proteins seen in
P. falciparum21.
Two molecules of this trafﬁcking machinery previously shown
to be essential for the transport of PfEMP1 to the RBC surface are
SBP1 (ref. 22) and MAHRP1 (ref. 23). Both proteins belong to the
PEXEL-negative exported proteins (PNEPs)24 that lack the
PEXEL motif found in many exported proteins25. Parasites with
genetic ablations of either sbp1 or mahrp1 failed to cytoadhere to
receptors and endothelial cells in vitro17,18,20. In line with the
absence of PfEMP1 in rodent malarias and the notion of a
PfEMP1-speciﬁc transport machinery in P. falciparum iRBCs,
neither SBP1 nor MAHRP1 had previously been identiﬁed in
rodent malaria parasites. In fact, to our knowledge no PNEPs had
been reported that were conserved between P. falciparum and
rodent malarias. The only protein so far shown to be essential
for P. berghei CD36-mediated sequestration of schizont-infected
RBC is a PEXEL-positive exported protein, the schizont
membrane-associated cytoadherence protein (SMAC), a molecule
restricted to rodent malaria parasites that is found in the
cytoplasm of iRBCs but not on their surface8.
Here we show that despite the absence of PfEMP1, P. berghei
expresses orthologues of both PfSBP1 and PfMAHRP1 that are
exported into the cytoplasm of iRBCs and are required for the
transport of a still unidentiﬁed parasite ligand that allows binding
of iRBCs to CD36 in vitro and sequestration in vivo. Strikingly,
the P. falciparum orthologues PfSBP1 and PfMAHRP1 comple-
ment the respective gene deletions in P. berghei. Our data indicate
evolutionary conservation of the machinery underlying parasite
virulence and highlight the P. berghei rodent model as an
adequate tool to analyse factors involved in malaria virulence.
Results
Orthologues of PfSBP1 and PfMAHRP1. Using amino-acid
similarity searches we detected putative PfSBP1 and PfMAHRP1
orthologues in all Plasmodium species listed in PlasmoDB
(www.Plasmodb.org) (Fig. 1a; Supplementary Fig. 1a). Rodent
Plasmodium species appear to possess two MAHRP1 versions
that we termed MAHRP1a and MAHRP1b, and are encoded by
tandem genes on the same locus. While the overall amino-acid
similarity between the SBP1 and MAHRP1 homologues was
rather low (Supplementary Fig. 1b–d), the architecture of the
protein features was similar (Fig. 1b) and all lack a PEXEL motif.
In addition, three other ﬁndings indicated that these proteins are
indeed orthologues. Firstly, the phylogenetic trees of these pro-
teins (Fig. 1c) are topologically concordant with the species tree of
malaria parasites26; secondly, a jackhmmer search arrived at the
same proteins originally detected by our similarity searches
(Supplementary Fig. 2); and ﬁnally, a re-examination of the
genomic location revealed that the genes encoding the MAHRP1
and SBP1 orthologues are in fact syntenic (Supplementary Fig. 3).
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Figure 1 | Orthologues of PfSBP1 and PfMAHRP1 in different Plasmodium species. (a) PlasmoDB IDs of the identiﬁed SBP1 and MAHRP1 orthologues.
Top, human and primate infecting Plasmodium species; bottom, rodent-infecting Plasmodium species. (b) Domain structure of selected SBP1 and MAHRP1
orthologues. Hatched grey boxes show repeats; H, histidine-rich regions; black, transmembrane domains (TM); blue/magenta, oligo E/D-K/R stretches.
The scale is 50 amino acids (aa). (c) Phylogenetic trees of the PfSBP1 and PfMAHRP1 orthologues. Scale bar indicates 0.3 expected substitutions per site;
BBP, Bayesian posterior probability.
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The synteny to the corresponding P. falciparum genes has
previously not been detected probably because it is obscured by
neighbouring synteny breaks.
Location and trafﬁcking of SBP1 and MAHRP1 are conserved.
In P. falciparum, SBP1 and MAHRP1 are exported into the iRBC
cytoplasm where they are located at parasite-induced host cell
modiﬁcations termed Maurer’s clefts. These structures are
believed to be important for the sorting of parasite proteins in the
iRBC, including the transport of the virulence factor PfEMP1 (ref.
27). To analyse the location in iRBC of the P. berghei orthologues
PbSBP1 (PBANKA_110130) and PbMAHRP1a (PBANKA114580)
(MAHRP1b (PBANKA114590) was not further analysed, as a GFP
fusion was poorly expressed in P. berghei blood stages), we raised
speciﬁc antisera against these proteins (Fig. 2a; Supplementary
Fig. 4). Immunoﬂuorescence assays with these sera showed that
PbSBP1 and PbMAHRP1a were exported into P. berghei iRBCs
where they were found in multiple discrete foci (Fig. 2b;
Supplementary Movie 1), resembling the typical labelling of
proteins located in P. falciparum Maurer’s clefts. In agreement
with such a localization, both PbSBP1 and PbMAHRP1a co-
localized with mCherry-tagged IBIS1 (Fig. 2b), a marker protein
of previously identiﬁed Maurer’s clefts-like structures in P. ber-
ghei28. Consistent with previous work28,29, these PbSBP1-positive
structures were highly mobile in the cytosol of P. berghei iRBCs
(Supplementary Movie 2). When P. berghei SBP1 was expressed
as a GFP-fusion protein in P. falciparum blood stages, PbSBP1-
GFP was detected in Maurer’s clefts together with the P.
falciparum Maurer’s clefts marker REX1 (ref. 30; Fig. 2c),
further supporting a localization at equivalent structures in
both parasite species. Furthermore, the ﬁrst 20 amino acids of
PbMAHRP1a and PbSBP1, a region mediating export in P.
falciparum PNEPs31, were sufﬁcient to export an established
reporter protein in P. falciparum into the host cell (Fig. 2d),
indicating evolutionary conservation of the export signals in these
orthologues and in PNEPs of different Plasmodium species in
general. Taken together these data establish that SBP1 and
MAHRP1 represent the ﬁrst known Maurer’s clefts proteins
conserved across all Plasmodium species analysed so far, and they
are amongst only a handful of conserved exported proteins
discovered to date21,26,32.
PbSBP1 and PbMAHRP1a are required for iRBC sequestration.
Next, we generated gene-deletion P. berghei mutants that lack the
genes encoding PbMAHRP1a and PbSBP1 (PbDmahrp1a
and PbDsbp1) (Supplementary Fig. 5). While no phenotypic
differences were observed between the gene-deletion mutants and
wild-type (wt) parasites during development in the mosquito
(Supplementary Fig. 6) or in the liver (Supplementary Fig. 7),
blood stages of the mutants exhibited an attenuated phenotype in
mice. While wt-infected C57B/6 mice died 7–9 days post infec-
tion as a result of complications typical for experimental cerebral
malaria, PbDmahrp1a- and PbDsbp1-infected mice did not
develop experimental cerebral malaria but died from hyperpar-
asitemia 25–28 and 32–45 days post infection, respectively
(Fig. 3a). A similar attenuation was also observed in infections in
Balb/c mice (Supplementary Fig. 8a). The parasitemia in the
PbDmahrp1a- and PbDsbp1-infected mice was comparable to
that of wt during the initial 2 days of infection, but was reduced
compared with wt thereafter (Fig. 3b). Both mutants were pre-
dominantly found in reticulocytes throughout the course of
infection, whereas virulent wt parasites were found in ery-
throcytes in the later course of infection (Supplementary Fig. 8b).
In addition, mice infected with the PbDmahrp1a and PbDsbp1
mutants showed a 3 and 3.6-fold increase in schizonts in the
peripheral blood circulation compared to wt infections, respec-
tively (Fig. 3c), indicating reduced sequestration of RBCs infected
with mutant schizonts.
To quantify sequestration of iRBCs in vivo, we next
generated Pbmahrp1a and Pbsbp1 gene-deletion mutants in
P. berghei parasites expressing the reporter protein ﬁreﬂy
luciferase (PbDmahrp1a-mCherryHsp70Lucef1a and PbDsbp1-
mCherryHsp70Lucef1a). Measuring of luminescence signals in
synchronous blood stage infections with fully virulent wt parasites
at 22 h post infection (when parasites are in the schizont stage)
showed a high accumulation of schizont-infected RBCs in the
lungs and adipose tissue but low accumulation in the spleen
(Fig. 3d), as previously described for P. berghei schizonts8. In
contrast, PbDmahrp1a and PbDsbp1 parasites showed strongly
reduced accumulation in the adipose tissue and lungs compared
with wt (Fig. 3d), which is typical for a loss of CD36-mediated
sequestration8. Conversely, signiﬁcantly increased accumulation
of parasites was detected in the spleens of mice infected with
PbDmahrp1a and PbDsbp1 mutants (Fig. 3d). Higher
accumulation in the spleen of non-sequestered schizonts has
been attributed to increased removal of non-sequestering
schizonts by the spleen8. Almost complete absence of mutant
parasites from the adipose tissue and lungs, and accumulation in
the spleen, was also evident after quantiﬁcation of parasite levels
in perfused organs removed from the mice (Fig. 3e). This
phenotype was conﬁrmed by intravital and ex vivo imaging of
organs with reporter mice-expressing GFP ubiquitously in all
tissues and infected with mutant and wt parasites expressing the
reporter protein mCherry (Pb-mCherryHsp70, PbDmahrp1a-
mCherryHsp70 and PbDsbp1-mCherryHsp70) (Fig. 3f;
Supplementary Movies 3 and 4).
The spleen plays a key role in clearance of iRBCs in both
human and rodent Plasmodium infections. It is known to
undergo major remodelling, including signiﬁcant enlargement
which has been associated with compromised splenic functions33.
P. falciparum and P. berghei parasites are believed to sequester in
the peripheral vasculature to avoid elimination in the spleen3,8. In
infections with the PbDmahrp1a and PbDsbp1 parasites, we
observed a strong increase in the size of spleens compared with
spleens of wt-infected control mice (Fig. 3g) and intravital
imaging showed higher accumulation and passage in the spleen of
PbDmahrp1a-mCherryHsp70 and PbDsbp1-mCherryHsp70 schizonts
compared with control schizonts (Supplementary Fig. 8c). Taken
together, the intravital and luminescence data are consistent
with decreased sequestration of the mutant parasites in adipose
tissue and lungs and increased accumulation and passage in
the spleen.
In vitro binding to CD36 depends on PbSBP1 and PbMAHRP1a.
The in vivo phenotypes of the PbDmahrp1a and PbDsbp1
mutants indicated reduced sequestration and raised the possibi-
lity that the cytoadherence properties of RBCs infected with these
parasites were altered. P. berghei iRBC containing schizonts were
previously shown to bind to CD36 (ref. 9), which is also a major
receptor for PfEMP1-mediated cytoadherence in P.
falciparum34,35. We therefore carried out in vitro binding assays
with schizont-infected RBCs. Binding to mouse CD36 was
signiﬁcantly lower in PbDmahrp1a and PbDsbp1 schizonts
compared with wt schizonts with both plate-coated CD36 or
CD36 expressed on CHO-745 cells (Fig. 3h). As this mirrors
the in vitro cytoadherence phenotype observed with the
corresponding mutants in P. falciparum17,18,20, this suggests
that despite the absence of PfEMP1 in P. berghei, the machinery
mediating surface display of an equivalent parasite ligand is
conserved. Loss of ligand surface expression resulting in impaired
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sequestration may be one reason for the reduced growth and
virulence of the mutants in vivo.
Loss of PfEMP1 expression in P. falciparum parasites results in
a reduced reactivity of iRBC to hyperimmune serum of infected
patients as measured by surface binding of the serum by FACS36.
To test whether the reduced adhesion to CD36 in the mutant
P. berghei parasites was also accompanied by a reduced display of
factors expressed on the iRBCs, we carried out similar FACS
experiments with hyperimmune sera raised in chronically
infected mice. Surface reactivity of hyperimmune sera in
PbDmahrp1a and PbDsbp1 schizont-iRBCs was signiﬁcantly
reduced when compared with wt to 60% and 45%, respectively
(Fig. 3i). This supports the idea that MAHRP1a and SBP1 are
indeed involved in the transport of certain parasite proteins to the
iRBC surface and that this is the reason for the reduced binding
to CD36.
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PfSBP1 and PfMAHRP1a complement P. berghei orthologues.
To explore further whether the P. berghei and
P. falciparum MAHRP1 and SBP1 have conserved functions,
we generated heterologous complementations of the P. berghei
gene-deletion mutants with the corresponding P. falciparum
molecules (PbDmahrp1aþPfmahrp1 and PbDsbp1þ Pfsbp1;
Supplementary Fig. 9). These heterologous complemented
mutants were analysed in parallel to a homologous com-
plementation of the PbDmahrp1a mutant with Pbmahrp1a
(PbDmahrp1aþ Pbmahrp1a). Complementation of PbDsbp1
with Pbsbp1 was not done, as proper cloning of the corresponding
plasmid in E. coli was not possible so far (likely due to the
41,000 bp of repeats in this gene). Importantly, both P. falci-
parum molecules, PbSBP1 and PbMAHRP1, restored the in vitro
binding of iRBC to CD36 of the corresponding mutants to470%
of wt (Fig. 4a). This heterologous complementation provides clear
evidence that the bioinformatically identiﬁed molecules PbSBP1
and PbMAHRP1a are indeed true functional orthologues
of PfSBP1 and PfMAHRP1a, despite their relatively low
conservation.
To conﬁrm successful heterologous complementation of the
mutants in vivo, we infected mice with the corresponding parasite
strains (Pfmahrp1 in PbDmahrp1a and Pfsbp1 in PbDsbp1). The
P. falciparum molecules restored both the growth phenotype
(Supplementary Fig. 10) and the virulence phenotype (Fig. 4b) of
the P. berghei mutants. The restoration of the phenotypes was
speciﬁc, as in mismatched complementations (Pfsbp1 in
PbDmahrp1a and Pfmahrp1 in PbDsbp1) that were analysed in
parallel, the phenotypes remained similar to the gene-deletion
mutants (Fig. 4b; Supplementary Fig. 10). Importantly, the
level of schizonts in the peripheral blood circulation in the
complemented mutants was comparable to wt parasites and to
that of the homologous complementation of the PbDmahrp1a
mutant with Pbmahrp1a (Fig. 4c). In agreement with the in vitro
binding data, this ﬁnding suggested restoration of sequestration
of the complemented mutants. Conversely, the mismatched
heterologous complementations did not lead to reduced schizont
levels (Fig. 4c).
Next, we generated complemented mutants that express
luciferase and measured the distribution of schizonts in organs
of infected mice by bioluminescence to quantitatively determine
their restored sequestration. Complementation of the PbDmahrp1a
mutant with Pbmahrp1a restored the schizont sequestration
phenotype, with accumulation of schizonts in the lungs and
adipose tissue, and reduced accumulation in the spleen (Fig. 5a).
The in vivo sequestration phenotypes were also restored in the
gene-deletion mutants that were complemented with the matched
P. falciparum molecules (PbDmahrp1a-mCherryHsp70Lucef1aþ
Pfmahrp1-mCherryef1a and PbDsbp1-mCherryHsp70Lucef1aþ
Pfsbp1), whereas no restoration was observed with the mismatched
complementations (PbDmahrp1a-mCherryHsp70Lucef1aþ Pfsbp1
and PbDsbp1-mCherryHsp70Lucef1aþ Pfmahrp1) (Fig. 5a,c).
Measurement of schizont accumulation in isolated organs
after perfusion revealed some interesting subtle differences.
Complementation with either the Pbmahrp1a or Pfmahrp1 of
PbDmahrp1a led to restored sequestration in all organs, similar to
controls (Fig. 5b). While the heterologous complementation of
the PbDsbp1 mutants with Pfsbp1 (PbDsbp1-mCherryHsp70
Lucef1aþPfsbp1) similarly restored the levels of schizonts
sequestering in the lungs and accumulating in the spleen, it
showed only 25% restoration of sequestration in adipose tissue at
22 h.p.i. (Fig. 5d). The unmatched complementations showed
sequestration levels in the organs that were similar to the gene-
deletion mutants, again conﬁrming the speciﬁcity of the effect.
Taken together these data support an evolutionarily conserved
and speciﬁc function of the SBP1 and MAHRP1 orthologues that
is a prerequisite for sequestration and virulence of iRBCs.
Discussion
Although iRBC of both P. berghei and P. falciparum sequester and
use similar host cell receptors for adherence to the microvascular
endothelium, the similarities of the tissue sequestration-induced
virulence between humans and rodents have been debated6. We
here establish for the ﬁrst time that components of the trafﬁcking
machinery speciﬁc for the transport of the ligands exposed on the
iRBC that bind to host cell receptors are evolutionarily conserved
among malaria parasites, although the ligands themselves are
clearly different between human and rodent Plasmodium
parasites. Our results in the rodent model, in particular the
heterologous complementation, further demonstrate that SBP1
and MAHRP1 play an important role in both, organ
sequestration and in virulence, results that are difﬁcult to
obtain in humans.
So far, the ligand(s) binding to host cell receptors such as CD36
(refs 8,9) have not been identiﬁed in P. berghei, despite the
identiﬁcation of proteins encoded by multigene families that are
transported to the surface of P. berghei iRBCs, speciﬁcally
members of the rodent-speciﬁc Fam-a family37. An exported
protein, the SMAC, has been implicated in CD36-mediated
P. berghei iRBC sequestration9. However, this protein, encoded by
a single copy gene, is not transported to the iRBC surface membrane
and orthologs are lacking in human malaria parasites8.
Figure 3 | Gene-deletion mutants PbDmahrp1aand PbDsbp1 show reduced schizont sequestration and virulence. (a) Survival of C57B/6 mice infected
with mutant and wt parasites (n¼9 mice per group, Po0.001, logrank test from Kaplan–Meier survival curve). (b) The course of parasitemia (mean±s.d.)
in C57B/6 mice (n¼ 15 mice per group) infected with 105 mutant or wt parasites. Signiﬁcant differences in parasitemia between wt and both mutants at
day 3, 6, 7 (Po0.001) and day 5 (P¼0.005) (two-tailed unpaired t-test). (c) Signiﬁcant increase in number of mutant schizonts in the peripheral blood
circulation compared with wt. Schizonts were quantiﬁed in Giemsa-stained smears of tail blood obtained 22 h after establishing synchronised infections
(ratio of the number of mutant to wt schizonts, n¼ 12 mice per group, P¼0.01; two-tailed unpaired t-test). (d) Representative distribution of sequestered
schizonts in mice with synchronised infections 22 h post infection of mutant and wt parasites that express luciferase as shown by measuring luciferase
activity (photons per s per cm2; shown as radiance, y; n¼ 15 mice per group). (e) Quantiﬁcation of parasite loads in isolated organs after perfusion 22 h
after synchronised infections with mutant and wt parasites expressing luciferase. Parasite loads were determined by measuring luciferase activity (photons
per s per cm2) and expressed relative to wt (n¼ 15 mice per group). (f) Representative intravital images (spleen, fat) and ex vivo (lungs) confocal images of
tissues from UBC-GFP mice 22 h after establishing synchronized infections of mutant and wt parasites that express mCherry. Insets in the images of fat
tissue are enlargements of the yellow boxes. Arrowheads indicate parasites. Size bars, 10mm. (g) Spleens of mutant-infected mice are signiﬁcantly larger
(spleen-to-body weight ratio) than spleens of wt-infected mice (n¼ 9 mice per group, *Po0.0001; unpaired Student’s t- test; infections were done with
106 parasites per mouse). Images of representative spleens at day 4 after infection are shown to the right. (h) In vitro binding of schizonts of mutant and wt
parasites to CD36-GFP-expressing CHO-745 cells (left) and to CD36 immobilized on plates (right). Binding is expressed as % of wt (n¼ 6, *Po0.0001;
two-tailed unpaired Student’s t-test). (i) Quantitative FACS analysis of surface reactivity of RBCs infected with wt and gene-deletion mutant schizonts
cultured ex vivo to mouse hyperimmune serum. Both deletion mutant schizonts exhibit signiﬁcantly reduced levels of surface labelling with P. berghei sera
compared to wt parasites. The geometric mean ﬂuorescence intensity (MFI) relative to wt is shown (%). (***P, 0.001, unpaired t-test).
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Further research is required to identify the rodent malaria ligand
which will greatly enhance studies on the relationship between
iRBC sequestration and virulence in rodent malaria models. The
mutants generated in this study lacking expression of SBP1 and
MAHRP1a are useful tools to identify such ligands, for example
by larger scale screening assays to identify proteins that are absent
on the surface of iRBC of these schizonts, for example members
of the Fam-a multigene family37,38.
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Figure 4 | Heterologous complementation of the mutants PbDmahrp1a and PbDsbp1 with Pfmahrp1 and Pfsbp1 rescues binding of iRBCs to CD36 and
virulence phenotype. (a) The matched complemented mutants showed signiﬁcantly increased binding to puriﬁed CD36 compared with the gene-deletion
mutants (binding indicated as % of wt; *Po0.0001, one-way ANOVA, Tukeys post hoc test.; n¼ 3). (b) Survival of C57B/6 mice infected with matched
complemented mutants was signiﬁcantly increased in comparison with the mutants and the mismatched complemented mutants (n¼9 mice per group,
Po0.001, logrank test from Kaplan–Meier survival curve). (c) Signiﬁcant decrease in number of schizonts in the peripheral blood circulation in matched
complemented mutants compared with the gene-deletion mutants and to mismatched complemented mutants. Schizonts were quantiﬁed in Giemsa-stained
smears of tail blood obtained 22h after establishing synchronised infections (n¼9 mice per group; *Po0.0001, one-way ANOVA, Tukeys post hoc test).
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Figure 5 | Heterologous complementation of the mutants PbDmahrp1a and PbDsbp1 with Pfmahrp1 and Pfsbp1 rescues the schizont sequestration
in vivo. Representative distribution of schizonts in mice infected with the matched and mismatched complementation of the PbDmahrp1a (a) and PbDsbp1
(c) parasites compared to wt and uncomplemented parasites (photons per s per cm2; shown as radiance, y). (b,d) quantiﬁcation of parasite loads in
isolated organs after perfusion (relative luminescence intensity (photons per s per cm2) compared to wt-infected mice) obtained 22 h after establishing
synchronised infections with luciferase-expressing wt, mutant and complemented parasites (n¼ 9 mice per group; *Po0.0001, one-way ANOVA, Tukeys
post hoc test).
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PbSBP1 and PbMAHRP1a co-localize with the protein IBIS
which is a rodent Plasmodium-speciﬁc protein39 that is located in
previously described Maurer’s clefts-like structures in P. berghei
iRBC28. Our data indicate that these structures in P. berghei iRBC
indeed serve similar function as the Maurer’s clefts in
P. falciparum. Strong support for this are our observations that
P. falciparum SBP1 and MAHRP1 were able to complement the
functions of PbSBP1 and PbMAHRP1, both with respect to the
sequestration and virulence phenotypes. The complemented gene-
deletion mutants showed restoration of nearly all phenotypes
close to wt, except for the adipose tissue sequestration in the
complementation of the SBP1 mutant which was only partly
restored. It is possible that complementation results in a lower
density of the parasite ligand on the surface compared with wt
parasites, which might lead to differences in the sequestration
phenotype between tissues with different receptor densities.
However, only when the P. berghei ligand has been identiﬁed,
questions related to ligand expression on iRBC and its relationship
with sequestration in different organs can be addressed.
The absence of SBP1 and MAHRP1 expression clearly
affected the growth rate of blood stages in the mouse. A reduced
growth rate had also been observed for a P. berghei mutant
lacking expression of SMAC that showed a reduced sequestration
of iRBC8. For this mutant it was shown that the decreased
multiplication of blood stages was due to the reduced sequestration
phenotype and thereby an increased removal of schizonts from the
blood circulation by the spleen. It is therefore likely that the
reduced CD36 binding and the ensuing lack of sequestration
of the SBP1 and MAHRP1-deﬁcient mutants is at least in part
responsible for the reduced growth rate. The important role of the
spleen is also clear from the increased accumulation of the gene-
deletion parasites in this organ and the strongly enlarged spleens in
mice infected with these mutants. This enlargement indicates a
marked restructuring of this organ, which may also affect clearance
of iRBC as has been previously suggested40,41.
It is interesting to note that the mutants showed a more
restricted preference for growing in reticulocytes compared with
wt parasites. Although P. berghei ANKA parasites have a strong
preference for invading and growing inside reticulocytes38, they
can invade erythrocytes at higher parasitemias when reticulocytes
become a limiting factor12,42. In the sbp1 and mahrp1a gene-
deletion mutants most parasites were found in reticulocytes, even
at higher parasitemias. Although the stricter preference of
invading reticulocytes may affect the growth rate later in
infection, it does not account for reduced sequestration of the
Pbsbp1 and Pbmahrp1a gene-deletion mutants since CD36-
mediated sequestration of schizonts is independent of their
presence in reticulocytes or erythrocytes9,12.
Our studies highlight unexpected similarities in the molecular
machinery underlying parasite sequestration of divergent Plas-
modium species. We provide the ﬁrst evidence for the presence of
proteins in Maurer’s clefts-like structures that play a role in
sequestration of rodent malaria and that are orthologues of
proteins involved in the transport of the major sequestration and
virulence protein PfEMP1 of the human parasite P. falciparum.
The conservation of this machinery indicates that the rodent
malarias can be powerful models to study sequestration and
virulence in vivo with relevance for human disease and that the
creation of falciparumized P. berghei expressing P. falciparum
virulence factors may be feasible. Such transgenic P. berghei
parasites would be invaluable tools for testing inhibitors that
block P. falciparum sequestration.
Methods
Identiﬁcation of SBP1 and MAHRP1a in other Plasmodia. PfSBP1 and
PfMAHRP1 protein sequences were used in BLAST searches in Plasmodb (v5.5) to
identify the orthologues in other Plasmodium species. Initially the now annotated
orthologues in Plasmodium vivax and Plasmodium knowlesi were identiﬁed and
used as further sequences to conduct BLAST searches in PlasmoDB. This revealed
the rodent Plasmodium homologues.
To conﬁrm the sequence initially identiﬁed by BLAST, we used a HMM-based
approach to identify orthologues of PfSBP1 and PfMAHRP1: low complexity
amino-acid regions of PfSBP1 and PfMAHRP1 were removed with the SEG
algorithm43, using the following parameter: window¼ 12; lowcut¼ 2.3 and
highcut¼ 2.5. Subsequently, a jackhmmer search44 was conducted against the
annotated protein sets of P. falciparum (3D7), P. vivax (Sal-1), P. knowlesi (H),
Plasmodium cynomolgi (B), Plasmodium chabaudi (AS), Plasmodium yoelii
(17XNL) and P. berghei (ANKA), as deposited in PlasmoDB v11.1 (ref. 45), using
an e-value inclusion threshold of 0.001. Orthologues were aligned with MAFFT v7
(ref. 46) using the E-INS-i routine47.
For phylogenetic analyses, the best ﬁtting amino-acid substitution models were
selected with ProtTest v2.4 (ref. 48) using the Akaike information criterion and
Bayesian analyses were conducted with MrBayes v3.2 using the following
parameters: JTTþG and JTTþ IþG models were used for SBP1 and MAHRP,
respectively; analyses were run for 5,000,000 generations; every 1,000th generation
was sampled and the ﬁnal 37,500 samples were used for tree reconstructions.
Animals. The mouse lines used were Balb/c mice (Harlan laboratories, Nether-
lands, and University of Bern Tierstall, Switzerland), C57B/6 mice (Harlan
laboratories, Netherlands); and transgenic UBC-GFP C57B/6 mice (Institute of Cell
Biology (IZB), University of Bern, Switzerland). All studies were done in female
5–8-week-old mice. Mice used for bioluminescence experiments were housed
under speciﬁc pathogen-free conditions at the Theodor Kocher Institute (TKI) of
the University of Bern, Switzerland. All other mice were housed at IZB (University
of Bern, Switzerland). Mice were maintained under a 12 h light and 12 h dark cycle.
All experiments were performed with the approval of the Animal Research Ethics
Committee of the Canton Bern, Switzerland (Permits 81/11 and 105/10),
and the University of Bern Animal Care and Use Committee, Switzerland.
All measurements performed for either bioluminescence or intravital microscopy,
were performed under isoﬂuorane or xylazine/ketamine anaesthesia, and all efforts
were made to minimize suffering.
P. berghei ANKA reference lines. Three P. berghei ANKA parasite lines were
used as reference: wt P. berghei ANKA; line 1804 mCherryHsp70 (from the PbANKA
GIMO motherline 1596cl1, Leiden)49; and line 1868 mCherry Hsp70Lucef1a (from
the PbANKA 1596cl1 GIMO motherline, Leiden)50.
Plasmid constructs. To express a C-terminal GFP fusion of PbSBP1 in P. berghei,
the full-length coding region of Pbsbp1 was PCR ampliﬁed with primers
PbSBP1-bam-fw and PbSBP1-bam-rv (all the primers used in this work are
described in Supplementary Table 1) and cloned into BamHI digested pL0017; this
plasmid had been obtained through the Malaria Research and Reference Reagent
Resource Centre (MR4) deposited by Andy Waters (MR4 no., MRa-786). For the
expression of PbSBP1-GFP in P. falciparum, its coding region was PCR ampliﬁed
using primers PbSBP1-KpnI-fw and PbSBP1-AvrII-rv and cloned KpnI/AvrII
into pARL1a51. To test for exporting regions in P. berghei PNEPs, the sequence
encoding the ﬁrst 20 amino acids of PbMAHRP1a-GFP and PbSBP1 were fused to
the mTRAP reporter31. For this the primer KpnI-PbMAHRP1a1-20-mTRAP_F
and KpnI-PbSBP1-1-20-mTRAP_F, were each used with primer mTRAP rev
(AvrII)31 to obtain the respective inserts which were cloned KpnI/AvrII into
pARL1a-GFP.
To generate the gene-deletion constructs, 1,129 bp of the PbSBP1 50UTR
(including the ﬁrst 41 bp of the gene) and 1,000 bp immediately downstream of the
stop codon were PCR ampliﬁed with primers PbSBP1-5utre-kpnfw2 and PbSBP1-
50-utr-aparv2 as well as PbSBP1-30utr-ecorIfw and PbSBP1-30utr-notrv,
respectively and cloned KpnI/ApaI and EcoR1/NotI into pOBconGFP52, a derivate
of pOB90 kindly donated by Oliver Billker. This resulted in plasmid pOBconGFP-
PbDSBP1. To generate the mahrp1a gene-deletion plasmid, 1,017 bp immediately
upstream of the start ATG were PCR ampliﬁed with the primers PbMAHRP1a-
50utr-kpnfw and PbMAHRP1a-50utr-aparv and 1,007 bp immediately downstream
of stop codon were PCR ampliﬁed with primers PbMAHRP1a-30utr-ecorIfw and
PbMAHRP1a-30utr-notrv and cloned KpnI/ApaI and EcoR1/NotI into pOBconGFP
to obtain pOBconGFP-PbDMAHRP1a.
To generate the complementation constructs, tgdhfr/ts in pL0017mCherry53
was replaced with hdhfr/ts (PCR ampliﬁed with primers hDHFR-F-AgeI and
hDHF-R-NheI) using AgeI and NheI to obtain pL17mCherry-hDHFR. Pbmahrp1a
was then PCR ampliﬁed with primers PbMAHRP1a_fw_BamHI and PbMAHRP1a_
rev_AvrII_part 2A_1 for 5 cycles followed by a second full PCR where the reverse
primer was exchanged with PbMAHRP1a_rev_ClaI_part 2A_part mCherry_MscI_2.
The resulting product contained the full mahrp1a gene followed by an AvrII site, the
2A skip peptide54,55, a ClaI site, 28 bp ofmcherry to span the sequence to themcherry
internal MsclII site and a MsclII site for cloning the product into pL17mCherry-
hDHFR. The PCR product was cloned BamHI/MscIII to obtain pL17-Pbmahrp1a-
2A-mCherryhDHFR and renamed pL17-PbMAHRP1a-AB. To generate the
heterologous add backs, this construct was digested with BamHI and AvrII to
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replace Pbmahrp1a with the genes encoding PfSBP1 and PfMAHRP1 (PCR
ampliﬁed with the primers PfMAHRP1_fw_BamHI and PfMAHRP1_rev_AvrII, as
well as PfSBP1_fw_BamHI and PfSBP1_rev_AvrII) to obtain pL17-PfMAHRP1a-AB
and pL17-PfSBP1-AB.
To obtain the plasmids for recombinant expression of parts of PbSBP1 and
PbMAHRP1a GST fusion proteins the DNA sequences encoding amino acids
494–600 (PbSBP1mid) and 601–723 (PbSBP1-C) of PbSBP1 as well as amino
acids 127–179 of PbMAHRP1a were cloned BamHI and XhoI into pGEX-6-P2
(GE Healthcare). The corresponding PCR products were generated using primers
PbSBP1_mid_fw_BamHI and PbSBP1_mid_rev_XhoI (PbSBP1mid), PbSBP1_C_
fw_BamHI and PbSBP1_C_rev_XhoI (PbSBP1-C), and PbMAHRP1a_C_
fw_BamHI and PbMAHRP1a_C_rev_XhoI (PbMAHRP1a). Inserts of all plasmids
were sequenced to verify that there were no undesired mutations.
Recombinant protein expression and production of antisera. PbMAHRP1a and
PbSBP1 GST fusion proteins were expressed in E. coli BL21 cells and puriﬁed using
glutathione-Sepharose (GE Healthcare) according to standard procedures. Antisera
were raised commercially (Eurogentec) in rabbits. The sera were puriﬁed using the
Nab Protein A Plus Spin Kit (Pierce) according to the manufacturer’s instructions.
Live cell imaging and immunoﬂuorescence assays. Immunoﬂuorescence assays
(IFAs) were carried out by one of two methods. Acetone ﬁxation of cells dried on
multiwell slides were done essentially as described56. Brieﬂy, blood of infected mice
were washed in PBS, applied to 10-well glass slides and allowed to air dry.
The slides were placed into 100% acetone for 20min. As an alternate new method,
cells were ﬁrst coated onto the multiwell slide using ConcanavalinA as described56,
followed by aspiration of all excess liquid on the well followed by immediate
submersion in 100% acetone before the slide can dry. This method was required to
detect PbMAHRP1a. Cells ﬁxed with either method were re-hydrated by adding
1 phosphate-buffered saline (PBS) to the wells followed by one wash in 1 PBS.
The cells were then blocked in 3% BSA in 1 PBS and primary sera were applied
for 1 h in blocking solution. The wells were then washed 5 in 1 PBS, the
secondary antibody applied for 1 h in blocking solution containing 1 mgml 1
40 ,60-diamidine-20-phenylindole dihydrochloride (DAPI) (Roche). The primary
antibodies were diluted 1/10,000 (rabbit anti-PbSBP1-mid), 1/5,000 (rabbit anti-
PbSBP1-C) and 1/1,500 (rabbit anti-PbMAHRP1a), and were all newly raised
(see ‘Recombinant protein expression and production of antisera’). Rrabbit
anti-REX130 was diluted 1/5,000 and the mouse monoclonal anti-GFP (Roche) was
diluted 1/500. Secondary antibodies used were goat anti-mouse Alexa Fluor 488,
donkey anti-rabbit Alexa Fluor 594 and goat anti-rabbit Alexa Fluor 647
(Life Technologies). The slides were mounted using DAKO antifade and imaged
with an Axioimager M1 equipped with a 100 /1.4 immersion lens and a
Hamamatsu Orca C4742-95 camera. Zeiss Axiovison software was used to capture
images. P. falciparum parasites expressing GFP-fusion proteins were viewed in
RPMI medium after staining the nuclei with 1 mgml 1 DAPI (Roche) for 10min
(ref. 57). Images were processed in Corel Photo-Paint X5. Quantiﬁcation of export
was done as described31 by counting of cells showing (i) only export, (ii) a mix of
exported and non-exported GFP signal and (iii) no export. This was done blinded
on three occasions by two researchers counting at least 50 cells per event per
person31. For three-dimensional reconstructions z-stacks were acquired using an
Olympus FV1000 confocal microscope and images processed with Imaris
(Bitplane). For time-lapse imaging, cells were imaged with a Zeiss Observer. Z1
confocal line scanning inverted microscope integrated into an LSM5 Live imaging
setup. Images were acquired using a Zeiss 63x Plan-Apochromat 1.4 Oil objective
and the Zeiss Efﬁcient Navigation 2009 software. After acquisition, contrast and
brightness levels were optimized using Image J software.
Intravital imaging and parasite passage. Five to 6-week-old female UBC-GFP
C57B/6 mice were used for all intravital imaging. Mice were infected with either
Pb-mCherryHsp70, PbDmahrp1a-mCherryHsp70 or PbDsbp1-mCherryHsp70 para-
sites. After reaching 5–6% peripheral parasitemia, blood was isolated by cardiac
puncture, and an in vitro schizont culture set up as previously published58. Naive
mice were infected with 106 schizonts, and 21–24 h later, intravital microscopy was
performed. A mixture of anaesthetics comprising 125mg kg 1 ketamine and
12.5mg kg 1 xylazine, was prepared and diluted in PBS (1:2:5). Mice were injected
with 100 ml per 20 g of the anaesthetic at 19 h post infection. The surgical procedure
involved a small incision to expose the spleen. The exposed spleen was glued to a
microscope cover glass (VWR, 24 50mm, No.1), and imaged with a Zeiss LSM5
confocal microscope, using a 63 oil immersion objective. Animal body
temperature was maintained at 37 C using a temperature-controlled incubation
chamber. Simultaneous imaging was performed with the HeNe 488 and HeNe 594
lasers to acquire GFP and mCherry images from the host and parasite respectively,
in a 512 512 ﬁeld of view (speed 4, zoom 1.5, Pinhole 1.0). Between 50 and 100
different ﬁelds of view were selected in the mouse spleen, and images acquired
every 500ms for 5min. Experiments were done in triplicate mice for each mutant
and wt parasite line. Line scans were positioned at various depths of the vessel, and
video-rate imaging was used to record blood and parasite ﬂow in mutant and wt
P. berghei-infected mice. We generated algorithms to calculate blood ﬂow through
various vessel subsets in each movie produced. Vessels away from bifurcations, and
with high signal-to-noise ratio, were selected for further image processing. During
intravital imaging, the adipose tissue, and liver were similarly imaged. These and
the lungs, heart, and kidneys, were extracted, embedded in O.C.T. compound
(Tissue Tek), and frozen for 20 mm cryosections and ﬂuorescence image analysis
that was carried out with a Leica SP8 microscope, 63 oil immersion lens. Images
were analysed by Imaris and Fiji.
Protein extraction and western blotting. For P. berghei parasite protein extracts,
blood of infected mice was washed twice in 1 PBS and infected red blood cells
puriﬁed on a Percoll gradient59 as described for P. falciparum60. The puriﬁed
infected RBCs were washed thrice with 1 PBS, the pellet lysed in Laemmli
sample buffer and the proteins separated on 10% SDS PAGE gels followed by
transfer to nitrocellulose membranes (Schleicher & Schu¨ll) in a tank blot device
(BioRad). The blots were blocked in 5% milk in 1 PBS and reacted with the
following rabbit-derived antibodies: anti-PbSBP1-mid (1:200’000), anti-PbSBP1-C
(1:1’000), anti-PbMAHRP1a (1/500), anti-PfSBP1 (1/1,000) and anti-PfMAHRP1
(a kind gift of Hans-Peter Beck) (1/2,500) for 2–4 h hours. After 5 washes in
1PBS, goat anti-rabbit horseradish peroxidase-conjugated secondary antibody,
diluted 1/2,500 (Dianova), was applied for 1 h, the membrane washed, reacted with
ECL (GE Healthcare) and the signal detected using X-ray ﬁlms. Alternatively,
secondary antibodies were anti-rabbit IgG 800CW IRDye or IgG 680LT IRDye
(both 1:10’000) and an Odyssey Imaging system (Li-Cor Bioschiences) was used
for detection.
Generation of transgenic PbDsbp1 and PbDmahrp1a parasites. Transfection
and selection of P. berghei ANKA mutant parasite lines was performed as
previously described58. Brieﬂy, the pOBconGFP-PbDSBP1 and pOBconGFP-
PbDMAHRP1a plasmids, were linearized (using NotI and KpnI for pOBconGFP-
PbDSBP1 and NotI and SapI, or NotI and PvuII for pOBconGFP-PbDMAHRP1a).
Schizonts from each respective reference line were isolated, and transfected with
the linearized plasmids using the nonviral Nucleofactor technology. Transfected
parasites were injected by intravenous injection into Balb/c mice. PbDmahrp1a and
PbDsbp1 mutant parasites were selected via administration of 70 mg pyrimethamine
per ml of drinking water. Following successful selection of transgenic parasites
(as determined by ﬂuorescence), mice were bled by intracardiac puncture and
screened by integration-PCR for determination of gene-deletion status. Several
clonal PbDmahrp1a and PbDsbp1 parasite lines were generated in two ways,
namely, limiting dilution and detached cell injection, as previously described58,61.
In the resulting clonal lines, correct integration of the DNA constructs was
determined by PCR using the primers listed in Supplementary Table 1. Green
ﬂuorescence of the gene-deletion parasites was conﬁrmed microscopically.
Complementation of PbDmahrp1a and PbDsbp1 lines. Two different clones of
the PbDmahrp1a and PbDsbp1 lines in the wt and the Pb1868 (Pb-mCherryHsp70
Lucef1a) background were selected, and used for generation of complemented lines.
Constructs pL17-PfMAHRP1a-AB and pL17-PfSBP1-AB encoding full-length
P. falciparum MAHRP1 and SBP1, as well as P. berghei mahrp1a (construct
pL17-PbMAHRP1a-AB) were used to transfect the PbDmahrp1a and PbDsbp1
lines. Parasites containing the constructs were selected by administration of
WR99210 into mice and cloned, resulting in the transgenic lines PbDsbp1þPfsbp1,
PbDsbp1þPfmahrp1, PbDmahrp1aþ Pfmahrp1, PbDmahrp1aþ Pfsbp1 and
PbDmahrp1aþ Pbmahrp1a. Green and red cytoplasmic ﬂuorescence of the
add-back parasites was conﬁrmed microscopically.
Mosquito-stage characterization. Five- to six-week-old female Balb/c mice were
pre-infected with blood stage transgenic parasites and maintained under pyr-
imethamine treatment in the drinking water. Upon ﬁrst appearance of parasites in
the peripheral blood, naive 5–6-week old female Balb/c mice were phenylhydrazine
(PH)-treated. Two–three days post PH-treatment, the pre-infected mice were bled
by intra-cardiac puncture, and infected blood was passaged into the PH-treated
mice. Three days post infection, upon observation of exﬂagellation in the
peripheral blood, the infected mice were used to feed Anopheles stephensi female
mosquitoes. Ten to eleven days following the blood meal, infected mosquitoes were
sorted via ﬂuorescence detected in the midguts. Pools of 30 infected mosquitoes per
P. berghei line were dissected and the midguts isolated to evaluate oocyst forma-
tion, timing and numbers. Oocysts were ﬁxed in 2% PFA for 10min, and imaged.
Quantiﬁcation of infected midguts from the different clones was performed using a
previously described semi-automated method62. At days 16–28 post-blood meal,
salivary glands were dissected, and sporozoites isolated from 60 mosquitoes pooled
into groups of 5 in 2 independent experiments. The tubes containing the collected
sporozoites were coded and sporozoite numbers were counted using a Neubauer
chamber, and compared among P. berghei transgenic and wt lines. Counting was
blinded.
HeLa cell culture and in vitro liver-stage infection assays. In parallel to
mosquito-stage characterizations, sporozoites from wt and gene-deletion lines were
isolated to perform in vitro infections of HeLa cells as described below. HeLa cells
(a generous gift by Robert Menard, Pasteur Institute, Paris) were maintained in
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complete MEM containing Earle’s Salts Medium, supplemented with 10% heat-
inactivated fetal calf serum (FCS), 1% L-Glutamine and 1% penicillin-streptomycin.
Cells were maintained at 37 C in a 5% CO2 cell incubator. Four times 104 cells
were seeded into 24-well plates for infection assays. Sporozoites of wt and gene-
deletion parasites were prepared from dissected salivary glands, incubated in
complete MEM media containing Amphotericin B (2.5 mgml 1) (10 -AT
medium), and added to the 24-well plates containing monolayers of HeLa cells.
Following infection, cells were incubated with 1 AT medium at 37 C and 5%
CO2 for 12, 24, 36, 48, 56 and 60–65 h. At 12 h post infection, wt and mutant
parasites were compared in their HeLa cell invasion capacity. At 24, 36, 48 and 56 h
post infection, wt and gene-deletion lines were analysed by ﬁxed immuno-
ﬂuorescence assay for size and PVM morphology. At least 100 infected cells were
imaged and further analysed. Cells were ﬁxed with 4% paraformaldehyde, per-
meabilized with 0.1% Triton X, and stained with anti-GFP or anti-RFP; anti-EXP1
and/or anti-UIS4 antibodies, and DAPI. Parasites from all time points were
compared in terms of size and PVM morphology. Finally, detached cell/merosome
generation—as a marker of successful liver cycle completion—was quantiﬁed at
60–65 h post infection and compared between wt and mutant parasites.
Determination of parasitemia and survival assays. To assess parasitemia over
time and for the survival assays, 6-week old female Balb/c and C57B/6 mice were
infected by intravenous (i.v.) injection, with 104–106 schizonts from in vitro schizont
cultures58 of individual clones of wt, PbDmahrp1a and PbDsbp1 lines in the
mCherryHsp70Lucef1a background. From day 1 post infection, Giemsa-stained blood
smears were obtained for analysis of parasitemia and life cycle stage distribution,
leukocytes and additional haematological features. Additionally, parasites were
collected for bioluminescence in vitro assays, and FACS analysis for total parasitemia
determination. Parasitemia was followed daily until the mice exhibited symptoms of
anaemia or the onset of cerebral malaria, at which point the mice were euthanized.
We assessed the gene-deletion mutant or wt status of the parasites with overall mouse
survival in a univariate Cox proportional hazards model, and Kaplan–Meier curves.
Parasitemia growth and reticulocyte preference were quantiﬁed by two independent
observers one of whom was blinded to the wt or mutant status of the parasites and the
time post infection represented in the Giemsa smears. Experiments were repeated at
least 3 times, with 5 mice per parasite line.
Bioluminescence in vivo and organ ex vivo imaging. Schizont sequestration was
imaged using luciferase-expressing wt, gene-deletion mutant, and complemented
parasites, in a bioluminescence in vivo imaging system (IVIS 100; Caliper Life
Sciences—f/stop, 1; no optical ﬁlter) both, in vivo (3min exposure; 10min post-
substrate injection; 8 binning; 12.5 cm ﬁeld view) and ex vivo (30 s exposure and
3min post-substrate injection; 8 binning; 10 cm ﬁeld view). Sequestration pat-
terns at 22–24 h post invasion in synchronous infections were monitored in Balb/c
and C57B/6 mice, and normalised to schizont levels of the wt control. Synchro-
nized infections were established by schizont puriﬁcation, isolation, and injection
as previously described. Mice were anaesthetized using 2.5% isoﬂuorane, and 100 ml
of the substrate RediJect were injected intraperitoneally. Following whole-body
imaging, mice were euthanized, and perfused with 1 PBS to remove unbound
schizonts. Individual organs including the lungs, heart, liver, adipose tissue and
spleen, were removed from infected mice following perfusion. Acquired data were
analysed using the programme Living Image 4.4. Experiments were repeated a
minimum of three times, with 3–5 mice per parasite line.
Histology. For histology, UBC-GFP transgenic C57B/6 or wt C57B/6 mice were
ﬁxed with 2% PFA by intracardiac perfusion. Adipose tissue, lungs, liver, heart,
kidneys and spleens were removed for further processing. Fixed tissues were
embedded in parafﬁn and 20–50 mm sections were stained with H&E or Giemsa,
and number of parasites per vessel area was quantiﬁed. The organs of at least 3
mice per parasite line were analysed by histology.
Splenomegaly. To determine splenomegaly scores, the spleens of mice infected
with gene-deletion mutant, wt and complemented lines were removed at various
time points post infection (uninfected controls, and days 1, 3, 5 and 7 post
infection). Before removal of the spleens, mice were weighed. After removal, the
weight of the spleen was recorded for percentage calculation (spleen-to-body
weight).
In vitro CD36 binding assays. For in vitro measurement of the adhesion of
mutant and wt P. berghei parasites to CD36-coated dishes recombinant mouse
CD36/Fc chimera (purchased from R&D) was used. Triplicate plastic dishes were
coated with protein A (BioVision) diluted at 20 mgml 1 in PBS (pH 9.0) or
PBS-containing 1% (wt/v) bovine serum albumin (BSA) for the control for 1 h at
37 C in a cell culture incubator. Dishes were washed three times with PBS (pH 7.4)
to remove unbound protein, and blocked with PBSþ 1% BSA at 4 C overnight.
After washing once with PBS, plates were coated with recombinant mouse CD36
(100, 10, 5, 2 and 1 nM) or PBS-containing 1% BSA (cell culture grade) for 3 h at
37 C in a cell culture incubator. Plates were washed a further three times with PBS,
and incubated once more for 30min with 1% BSA in PBS. In parallel, schizonts
from all strains were isolated following 16 h of ex vivo maturation as previously
described8,58. The matured schizonts (106) were added to binding medium (RPMI-
1640, 25mM HEPES, 25mgml 1 gentamycin, 2mM L-glutamine, 10% FCS) and
allowed to bind in individual compartments for 1 h. After 1 h, dishes were placed in
an orbital shaker for 1 h, and ﬁnally, washed with PBS before measurement of
bound parasites by ﬂuorescence microscopy. Each condition was done in triplicate,
and each experiment repeated 3–5 times. The differential binding of wt versus
gene-deletion mutant parasites was determined based on quantiﬁcation of bound
parasites per mm2 by mCherry ﬂuorescence.
For binding assays with CD36 expressed on cells, the following Chinese
hamster ovary (CHO) cells were used as per a setup previously described for
P. falciparum63. CHO-K1 (a kind donation by Phillip Odermatt and Daniel
Schuemperli), CHO-745 (a kind donation by Beat Trueb) and CHO-745
transfectants expressing CD36, were cultured in DMEM medium supplemented
with 10% fetal calf serum, 1% L-glutamine, 1% L-proline and 1% penicillin/
streptomycin. CHO-745 cells were transfected with GFP-tagged CD36, using
nucleofactor technology. Receptor surface expression in transiently and stably
transfected cells was monitored by ﬂow cytometry on a weekly basis. For binding
assays, individual CHO cell lines were grown to 70% conﬂuence, and 104 cells
seeded in 33mm polystyrene dishes (In Vitro Scientiﬁc) 24–36 h before binding
assays. For binding, CHO cells were washed three times with pre-warmed binding
media (RPMI-1640 plus 0.1% BSA). Schizonts were puriﬁed as previously
published8,58, and 106 schizonts overlayed onto the CHO cells and incubated for
1 h at 37 C. Thereafter, non-binding erythrocytes were removed by transferring
the binding dishes to an orbital shaker for 30min, and then by gently ﬂooding the
dishes with warm binding medium and replacing the medium three times. Binding
of wt and gene-deletion parasite mutants was quantiﬁed under a confocal
microscope (Leica SBP8, 100 objective) or a ﬂuorescence microscope (Leica
L550b), by determining the number of schizonts adhering to at least 500 cells.
Binding was expressed as number of schizonts bound per 100 cells. The binding
experiments were performed by two independent researchers, one of whom was
blinded to the mutant or wt status of the parasites.
Flow cytometry to analyse P. berghei surface antigens. FACS-based detection of
surface antigens was done similarly to what was previously published15. Mice
infected with wt, MAHRP1- and SBP1-deletion mutants were exsanguinated by
cardiac puncture at day 5 post infection (5–10% parasitemia). Establishment of
in vitro schizont cultures and isolation of schizonts were carried out as previously
described58. Schizonts were washed 1 in RPMI and blocked for 1 h in 1% casein
in RPMI (blocking solution). Six million schizonts per condition were incubated
for 1 h in serum harvested from P. berghei semi-immune mice previously infected
with wt parasites, (or non-immune mice), essentially as described previously64:
C57B/6 mice were infected with wt P. berghei, and 5 days post infection treated
with a curative dose of chloroquine and sulfadiazine. Following disappearance of
parasites from the periphery, the mice were re-infected, and the procedure repeated
a total of four times, after which the serum was isolated. The serum was used 1:20
in blocking solution. After three washes with blocking solution, cells were
incubated for 1 h in the dark, with goat anti-mouse Cy5 (1:2,000, Dianova),
then washed a further three times. Following the last wash, schizonts were
resuspended in 500 ml of 1 PBS, and analysed with a BD LSR II Flow Cytometer
(BD Biosciences). Gating was performed using BD FACSDiva Software
(BD Biosciences), and analysis performed using FlowJo. All incubations were
performed at 20–22 C. Following gating for erythrocytes and gating for
eliminating duplets, infected red blood cells were gated based on their tagging with
GFP and/or mCherry. Serum IgG binding for each sample (surface labelling) was
expressed as the geometric mean ﬂuorescence intensity (MFI) relative to wt, after
subtracting the MFI of uninfected erythrocytes.
Statistical analyses. All experiments were repeated a minimum of three times.
Mouse experiments were repeated with 3–5 mice per group each time. Data are
expressed as mean±s.e.m. The main statistical test used was the Student’s t-test.
For experiments involving multiple comparisons, we used multivariate analyses of
variance followed by post hoc within and between groups hypothesis testing.
All analyses were performed using STATA 13. All P values less than 0.05 were
considered to be statistically signiﬁcant.
Data availability. The authors declare that the data supporting the ﬁndings of this
study are available within the article and its supplementary information ﬁles, or
from the corresponding authors upon request.
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